NIH-funded research R01 grant

Understanding how viruses use lipids to replicate

Official title: Manipulation of lipid metabolism in (+)RNA virus replication

Funded at University of Chicago · NIH-11094809 · Data updated 2026-11-12

This study looks at how some viruses change the fats in our cells to help them multiply, and it hopes to find new ways to create treatments that can stop these viruses from spreading.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startJune 7, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$410,000
NIH project number5R01AI173337-03
Project IDNIH-11094809 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would include individuals infected with (+) RNA viruses, such as those causing hepatitis C or other related viral infections.

Less likely to help

Patients with non-viral infections or those not affected by (+) RNA viruses may not receive any benefit from this research.

What this research studies

This research investigates how certain viruses manipulate the lipids in cell membranes to create environments that support their replication. By focusing on the endoplasmic reticulum, the study aims to uncover the mechanisms by which viral proteins alter lipid composition, particularly phosphatidyl choline, to enhance viral replication. The research involves detailed biochemical assays and cellular models to define the roles of specific enzymes and lipids in the viral life cycle. Patients may benefit from insights gained that could lead to new antiviral therapies targeting these processes.

Why it matters

Potential benefit: If successful, this research could lead to the development of novel antiviral treatments that disrupt viral replication mechanisms.

How similar studies have gone: Other research has shown promising results in targeting lipid metabolism for antiviral strategies, indicating that this approach may be viable.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Randall, Glenn C — University of Chicago
  • Study coordinator: Randall, Glenn C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.